Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/40602
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invite to open peer review
Title

Decreased STAMP2 expression in association with visceral adipose tissue dysfunction

AuthorsMoreno-Navarrete, José Maria; Ortega, Francisco J.; Pérez-Pérez, Rafael CSIC ORCID; Ricart, Wifredo; Peral, Belén CSIC ORCID; Fernández-Real, José M.
KeywordsSTAMP2
Human obesity
Gene expression
Type 2 diabetes
Issue Date17-Aug-2011
PublisherEndocrine Society
CitationJournal of Clinical Endocrinology and Metabolism 96(11): E1816-E1825 (2011)
Abstract[Context]: Six-transmembrane protein of prostate 2 (STAMP2) is a counter-regulator of inflammation and insulin resistance according to findings in mice. However, there have been contradictory reports in humans. [Objective]: We aimed to explore STAMP2 in association with inflammatory and metabolic status of human obesity. [Design, Patients, and Methods]: STAMP2 gene expression was analyzed in adipose tissue samples (171 visceral and 67 sc depots) and during human preadipocyte differentiation. Human adipocytes were treated with macrophage-conditioned medium, TNF-α, and rosiglitazone. [Results]: In visceral adipose tissue, STAMP2 gene expression was significantly decreased in obese subjects, mainly in obese subjects with type 2 diabetes. STAMP2 gene expression and protein were significantly and inversely associated with obesity phenotype measures (body mass index, waist, hip, and fat mass) and obesity-associated metabolic disturbances (systolic blood pressure and fasting glucose). In addition, STAMP2 gene expression was positively associated with lipogenic (FASN, ACC1, SREBP1, THRSP14, TRα, and TRα1), CAV1, IRS1, GLUT4, and CD206 gene expression. In sc adipose tissue, STAMP2 gene expression was not associated with metabolic parameters. In both fat depots, STAMP2 gene expression in stromovascular cells was significantly higher than in mature adipocytes. STAMP2 gene expression was significantly increased during the differentiation process in parallel to adipogenic genes, being increased in preadipocytes derived from lean subjects. Macrophage-conditioned medium (25%) and TNF-α (100 ng/ml) administration increased whereas rosiglitazone (2 μM) decreased significantly STAMP2 gene expression in human differentiated adipocytes. [Conclusions]: Decreased STAMP2 expression (mRNA and protein) might reflect visceral adipose dysfunction in subjects with obesity and type 2 diabetes.
Description10 páginas, 6 figuras, 2 tablas.-- et al.
Publisher version (URL)http://dx.doi.org/10.1210/jc.2011-0310
URIhttp://hdl.handle.net/10261/40602
DOI10.1210/jc.2011-0310
ISSN0021-972X
E-ISSN1945-7197
Appears in Collections:(IIBM) Artículos




Files in This Item:
File Description SizeFormat
JClinEndocrinolMetab_2011_Aug_17.pdf248,7 kBAdobe PDFThumbnail
View/Open
Show full item record

CORE Recommender

SCOPUSTM   
Citations

31
checked on Apr 3, 2024

WEB OF SCIENCETM
Citations

31
checked on Feb 14, 2024

Page view(s)

376
checked on Apr 18, 2024

Download(s)

284
checked on Apr 18, 2024

Google ScholarTM

Check

Altmetric

Altmetric


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.